Tauriga Sciences, Inc. (TAUG)

taug_logo_f_improf_179x131Many companies in the medical, wellness, and technology industries are expanding to the medical marijuana sector as it continues to show growth. Tauriga Sciences, Inc is one such company – it is a diversified biotechnology outfit that entered the marijuana space this year by acquiring a manufacturer of medical cannabis products.

Tauriga Sciences aims to build on its diversified portfolio by acquiring licenses, exclusive and non-exclusive rights, and entire businesses. Its featured subsidiaries are Microbial Robotics LLC (formerly Bacterial Robotics) and Pilus Energy LLC.

Microbial Robotics is a bio-engineering firm that ‘programs’ micro-organisms to produce microscopic robots. These can then be used in various applications such as reducing disease, cleaning water, growing foods, providing fuel, and producing therapeutics.

Meanwhile, Pilus Energy is a Tauriga-acquired subsidiary of Microbial Robotics. It uses genetically engineered bacteria that process wastewater to generate direct current electricity and produce useful gases and chemicals.

Founded in 2001, Tauriga Sciences formerly operated under various names such as New England Acquisitions, Inc, Atlantic Wine Agencies, Inc, and Novo Energies Corp. It changed to its current name in 2013.

Tauriga Sciences, Inc is now traded in the OTC markets as TAUG, with a market cap of USD 14.6 M. It is led by Dr. Stella Sung, Chairman, CEO, COO, and Interim CFO; Seth M. Shaw, VP for Strategic Planning; Dr. Lawrence A. May, Chief Medical Officer; and Ghalia Lahlou, Operations Manager. They are joined by Ian Harrison, VP and General Manager of Pilus Energy; and David Schweizer, VP of NuclearBot Development.


Yahoo! Finance: TAUG News

Latest Financial News for TAUG

Tauriga Sciences Inc. Launches Strategic Initiatives to Increase its E-Commerce Revenue as Well as Tauri-Gum Brand Visibility

The Company has a strong fulfilment infrastructure already in place, capable of supporting significant increases in daily E-Commerce activity.  Additionally, as disclosed during June 2019, the Company’s E-Commerce website is able to process credit card transactions. The Company is in discussions, with potential long-term partners, to achieve the above-referenced business objectives – relating to its E-Commerce business. Lastly, the Company continues to realize increasing market demand for its products and believes that it will report strong results for its current operating quarter (2nd Fiscal Quarter 2020).

Tauriga Sciences Inc. to Integrate QR Codes into Future Product Package Design(s)

New York, NY, July 31, 2019 -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the.

Tauriga Sciences Inc.’s CBD Infused Chewing Gum Available at More Than 100 Gas Stations in the Tri-State Area

New York, NY, July 11, 2019 -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the.

Tauriga Sciences Inc. Experiences Significant Growth and Momentum in its Business During Record Month of June 2019

Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™.  See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model.

Tauriga Sciences Inc. Presentation Today at 3:30-4:00pm EST at The MJ Micro Conference in Midtown Manhattan

New York, NY, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today confirmed that its Presentation at The MJ Micro Conference 2019 (the “Conference” or “MJ Micro”) will take place this afternoon between 3:30-4:00pm EST.  The location of the Conference is The Westin Grand Central Hotel – located in Midtown Manhattan (New York City).